Egyszerű nézet

dc.contributor.author Serafini G
dc.contributor.author Vazquez GH
dc.contributor.author Gonda, Xénia
dc.contributor.author Pompili M
dc.contributor.author Rihmer, Zoltán
dc.contributor.author Amore M
dc.date.accessioned 2019-04-01T06:43:22Z
dc.date.available 2019-04-01T06:43:22Z
dc.date.issued 2018
dc.identifier.citation journalVolume=268;journalIssueNumber=8;journalTitle=EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE;pagerange=757-768;journalAbbreviatedTitle=EUR ARCH PSY CLIN N;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/6647
dc.identifier.uri doi:10.1007/s00406-018-0875-5
dc.description.abstract Rates of 50-70% of residual symptoms referring to subsyndromal manifestations between episodes that do not meet the required criteria for episode definition were reported in bipolar disorder (BD). However, the specific role of these symptoms on the course of BD patients is poorly understood; thus, we aimed to investigate factors associated with depressive residual symptoms. Overall, 255 currently euthymic BD outpatients on maintenance treatment, including 95 (37.2%) males and 160 (62.8%) females, were consecutively recruited at the Section of Psychiatry, Department of Neuroscience, University of Genoa (Italy) and underwent detailed structured interviews, comprehensive clinical interviews, and clinical record reviews for assessment/collection of relevant information concerning the course of illness and clinical status including cross-referral of all available information. After categorizing subjects according to the presence/absence of residual symptoms, groups were compared along clinical variables and variables associated with residual symptoms were analyzed using multivariate analyses. Subjects with residual symptoms were less likely to report substance abuse (chi(2)(2) = 11.937, p </= 0.005) and lifetime psychotic symptoms (chi(2)(2) = 10.577, p = 0.005), and more likely to report higher illness episodes, longer duration of illness (t253 = 67.282, p </= 0.001; t253 = 10.755, p </= 0.001), and longer duration of current illness episode (t253 = 7.707, p </= 0.001) than those without residual symptoms. After multivariate analyses, a significant positive contribution to residual symptoms was given only by duration of current illness episode (beta = 0.003; p </= 0.05), and lifetime psychotic symptoms (beta = 1.094; p </= 0.005). Clinicians have to pay attention to minimize residual symptoms that may significantly impact on the course of BD and achievement of full remission between episodes.
dc.format.extent 757-768
dc.relation.ispartof urn:issn:0940-1334
dc.title Depressive residual symptoms are associated with illness course characteristics in a sample of outpatients with bipolar disorder
dc.date.updated 2019-01-04T10:00:01Z
dc.rights.holder NULL
dc.identifier.mtmt 3350912
dc.identifier.pubmed 29417206
dc.contributor.department SE/AOK/K/Pszichiátriai és Pszichoterápiás Klinika
dc.contributor.department SE/GYTK/GYHATAS/MTA-SE Neuropszichofarmakológiai és Neurokémiai Kutatócsoport
dc.contributor.department SE/GYTK/GYHATAS/NAP-A-SE Új Antidepresszív Gyógyszercélpont Kutatócsoport
dc.contributor.institution Semmelweis Egyetem


Kapcsolódó fájlok:

A fájl jelenleg csak egyetemi IP címről érhető el.

Megtekintés/Megnyitás

Ez a rekord az alábbi gyűjteményekben szerepel:

Egyszerű nézet